Lv2
148 积分 2024-04-29 加入
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
16天前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
28天前
已完结
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines
1个月前
已完结
Neoantigen-driven cancer vaccines in personalized oncology: progress, obstacles, and translational prospects
1个月前
已完结
Cancer mRNA vaccines: clinical application progress and challenges
1个月前
已完结
Current Progress and Future Perspectives of RNA-Based Cancer Vaccines: A 2025 Update
1个月前
已完结
Reacciones adversas a inhibidores de quinasa Janus: estudio de su incidencia y de factores predictivos en los pacientes con artritis reumatoide
3个月前
已完结
miR-146b-5p downregulates IRAK1 and ADAM19 to suppress trophoblast proliferation, invasion, and migration in miscarriage
4个月前
已完结
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
5个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
5个月前
已完结
皖公网安备34019202002308
